Houston innovator joins ESG roundtable, Rice names cohort of student startups, and more innovation news

short stories

In the latest round up of Houston innovation news you may have missed, student startups selected for a summer program, Texas might be among the best states for nurses, and more. Photo by Scott Halleran/Getty Images

It's been a busy season for the Houston innovation ecosystem, and for this reason, local startup and tech news may have fallen through some of the cracks.

In this roundup of short stories within Houston innovation, a software startup is focusing on diversity and inclusion, an angel network has a new partner organization, a Houston innovator is playing a major role in ESG, and more.

GoCo hosts its first-ever DEI Hackathon

GoCo is hosting its first hackathon. Photo via Getty Images

GoCo.io, a Houston-based human resources software-as-a-service company, is hosting its first hackathon for diversity, equity, and inclusion begining today, May 6, and continuing through tomorrow, May 7.

GoCo's entire staff is going to work for over 36 hours to build solutions aimed at promoting diversity, equity, and inclusion for small businesses.

"Building technology to help HR make a difference in the workplace is what we're all about at GoCo," says Allie Collins, head of GoCo's DEI Task Force, in a news release. "HR professionals are being called upon to make profound and meaningful changes to combat racism and inequities. We're hosting this event because our whole team is passionate about creating apps and resources to facilitate that change."

The competitors will be on teams and will present their projects on Monday, May 10, for a panel of judges.

Rice Alliance backs diversity-focused angel investment network

Maria Maso, CEO of baMa, has announced Rice Alliance as a partner organization. Photo courtesy of Nijalon Dunn

The Rice Alliance for Technology and Entrepreneurship has become a baMa champion of diversity for angel network baMa, or the Business Angel Minority Association.

"Rice Alliance aims to foster an innovative and entrepreneurial culture that not only values differences, but also elevates them as sources of strength and innovation," says Rice Alliance's managing director, Brad Burke, in a news release.

According to the release, baMa will help to introduce Rice to more diverse businesses. The angel network has already tapped into Rice's ecosystem with the $50,000 investment prize baMa awarded during the Rice Business Plan Competition in March.

"Diversity and education go hand by hand so counting with the support of Rice Alliance is a huge step in order to accomplish baMa's goal: close the investment gap in minority-led startups," says baMa CEO, Maria Maso.

Topl named to ESG council

Kim Raath will serve on CNBC's ESG Council. Photo courtesy of Topl

Kim Raath, CEO of Houston-based blockchain company, Topl, has announced that she has been invited to join the CNBC's ESG Council. She was selected among execs from large corporations like companies such as The HEINEKEN Company, Nestlé, IHG Hotels & Resorts, Nissan Motor Corporation, Bain & Company, Credit Suisse, and more.

"As a young startup, this is one of our most exciting milestones. Sitting at the table with industry leaders is great momentum for both Topl's success and our larger ESG mission," Raath writes in Topl's newsletter. "Traceable transparency in supply chains is a game changer for global commerce, and now Topl can learn from and collaborate with multinational corporations. This opportunity will help position our purpose-built blockchain as a solution to solve some of the biggest and most critical problems our world faces, and as we strive to build a more sustainable future for all."

The council is a roundtable of 30 business leaders across industries focused on the challenges posed by sustainability — and the strategies needed to overcome them, according to Raath.

Is Texas a good state for nurses?

A new report ranks states based on their opportunities and friendly environment for nurses. Photo via Getty Images

The Lone Star State's nursing industry was put to the test for a new report from WalletHub, a personal financial website. The study compared all 50 states based on opportunity and competition and work environment. Texas ranked No. 12 overall.

Ranked solely on opportunity and competition — which included evaluating salary, schools, nurses per 1,000 residents, and more — Texas came in at No. 11.

The top states on the list were Arizona, Washington, and Nevada, respectively.

Rice University announces OwlSpark's ninth cohort

Meet the 10 student startups that are joining the OwlSpark family this summer. Photo courtesy of OwlSpark

Rice University's student startup accelerator has named 10 startup teams to its ninth cohort, which kicks off later this month. OwlSpark's 2021 cohort includes teams from across industries — hospitality, sports, oil and gas, consumer, staffing, automotive and more. According to a release from Rice, these are the companies selected:

  • Capybara - a networked platform that facilitates the company-to-company transfer of IT employees with similar skill sets (for example, software developers)
  • ChckMate – a data-driven platform designed to improve customer dining experiences, drive loyalty and increase revenue
  • GatherX Analytics – an AI software platform that predicts location and quantity of hydrocarbon liquid dropout for use by the upstream oil and gas industry
  • HARK – an easy-to-use app designed to significantly enhance the way in which neurodivergent or cognitively impaired individuals communicate real-time with caregivers and loved ones
  • Home Maintainer - a comprehensive solution for homeowners to manage and simplify home maintenance and efficiency
  • OneLab - a robust cloud-based repository designed for effective organization and easy access to a body of data on a specific area of research
  • Oversox– waterproof, durable, sock-like coverings designed to easily slip over the outside of a shoe for use by the serious hiker
  • rutd – an enterprise software and mobile application that provides immediate, actionable, suicide prevention resources to military veterans and family members
  • Tailer – a training platform and sales tool for electric vehicle dealerships and sales personnel
  • Yellow Saffron Labs – a risk analysis platform that gathers datasets from peer-reviewed scientific publications for use by organizations to observe industry trends or upcoming scientific disruptions or discoveries

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings